Managing Patients at Risk of Medication Related Complications Requiring Dental Extractions in Primary Care

When undertaking dental extractions in modern dental practice, two of the complications that have the potential to cause most apprehension for clinicians are the risks of osteonecrosis of the jaws and uncontrollable haemorrhage. This is especially the case when treating older patients because of the increased likelihood of co-morbidities and accompanying polypharmacy which can predispose patients to these problems. Specific medications of concern to practitioners in relation to osteonecrosis risk are antiangiogenic and antiresorptive drugs. Patients taking dual antiplatelet therapy and direct oral anticoagulants require consideration in relation to bleeding risk. With these medications coming increasingly to the forefront over recent years, guidance has been developed by organisations such as the Scottish Dental Clinical Effectiveness Programme (SDCEP). Appropriate use of these guideline should ensure that patients felt to be at particular risk of these complications can frequently be safely managed in primary care. This article aims to provide advice on recognising patients at risk, and to discuss how to utilise key messages within published guidelines when making treatment decisions. The overall intent is to help primary care clinicians who are likely to encounter these patients more and more.

[1]  A. Exadaktylos,et al.  Severe Enoral Bleeding with a Direct Oral Anticoagulant after Tooth Extraction and Heparin Bridging Treatment , 2019, Case reports in emergency medicine.

[2]  H. Yoshida,et al.  Safety of tooth extraction in patients receiving direct oral anticoagulant treatment versus warfarin: a prospective observation study. , 2019, International journal of oral and maxillofacial surgery.

[3]  S. Patntirapong,et al.  Inhibition of macrophage viability by bound and free bisphosphonates. , 2019, Acta histochemica.

[4]  Z. Siudak,et al.  Safety of dental extractions in patients on dual antiplatelet therapy – a meta-analysis , 2019, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

[5]  A. di Lenarda,et al.  Should we fear direct oral anticoagulants more than vitamin K antagonists in simple single tooth extraction? A prospective comparative study , 2018, Clinical Oral Investigations.

[6]  S. Hsue,et al.  Management of dental extractions in patients on warfarin and antiplatelet therapy. , 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

[7]  Lin Li,et al.  Dental management of patient with dual antiplatelet therapy: a meta-analysis , 2018, Clinical Oral Investigations.

[8]  S. Patntirapong,et al.  Alteration of macrophage viability, differentiation, and function by bisphosphonates. , 2018, Oral diseases.

[9]  B. Atalay,et al.  Bleeding frequency of patients taking ticagrelor, aspirin, clopidogrel, and dual antiplatelet therapy after tooth extraction and minor oral surgery. , 2018, Journal of the American Dental Association.

[10]  Jonathan Pugh Oral health management of patients at risk of medication-related osteonecrosis of the jaw. , 2017, BDJ.

[11]  O. McCarty,et al.  Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies , 2017, Journal of thrombosis and haemostasis : JTH.

[12]  R. Khonsari,et al.  Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study. , 2016, Oral surgery, oral medicine, oral pathology and oral radiology.

[13]  C.-Y. Tsai,et al.  Dental extraction without stopping single or dual antiplatelet therapy: results of a retrospective cohort study. , 2016, International journal of oral and maxillofacial surgery.

[14]  Scottish Dental Clinical Effectiveness Programme (SDCEP) achieves NICE accreditation , 2016, Evidence-Based Dentistry.

[15]  M. Piccart,et al.  Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis , 2013, Advances in Therapy.

[16]  Jacques P. Brown,et al.  Five Years of Cenosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the First Two Years of the FREEDOM Extension , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  G. Colella,et al.  American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[18]  A. Goss,et al.  Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. , 2007, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[19]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[20]  L. Michaels Recurrence of thromboembolic disease after discontinuing anticoagulant therapy A study of factors affecting incidence , 1970, British heart journal.

[21]  National Institute for Health and Care Excellence (NICE) , 2019, The Grants Register 2020.

[22]  P. Babaji,et al.  Clinical Evaluation of Role of Dual Antiplatelet Therapy on Bleeding after Dental Extraction , 2018, Contemporary clinical dentistry.

[23]  J. Dunford,et al.  Differences between bisphosphonates in binding affinities for hydroxyapatite. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.